Renaissance Technologies - EYEPOINT PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$65,000
-51.5%
35,890
-55.9%
0.00%
Q2 2019$134,000
-80.2%
81,455
-78.5%
0.00%
-100.0%
Q1 2019$678,000
-46.6%
378,780
-43.6%
0.00%0.0%
Q4 2018$1,269,000
-65.9%
671,625
-35.6%
0.00%
-75.0%
Q3 2018$3,724,000
+59.2%
1,043,000
-7.2%
0.00%
+300.0%
Q2 2018$2,339,0001,124,3000.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$21,793,00011.58%
Kore Private Wealth LLC 202,366$105,0000.02%
BARD ASSOCIATES INC 335,750$175,0000.02%
HighTower Advisors, LLC 5,284,688$2,738,0000.01%
GSA CAPITAL PARTNERS LLP 126,529$66,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 654,200$339,0000.01%
Virtu Financial LLC 57,076$30,0000.01%
WEDBUSH SECURITIES INC 81,500$42,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 33,933$18,0000.00%
MATRIX ASSET ADVISORS INC/NY 39,500$20,0000.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders